Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation

Microbiome

Volumn 1, Issue 1, 2013, Pages

  Price, Katherine E ^a   Hampton, Thomas H ^a   Gifford, Alex H ^b   Dolben, Emily L ^a   Hogan, Deborah A ^a   Morrison, Hilary G ^c   Sogin, Mitchell L ^c   O'Toole, George A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c MARINE BIOLOGICAL LABORATORY   (United States)

Author keywords

Cystic fibrosis; Cystic fibrosis pulmonary exacerbation; Microbiome; Pseudomonas aeruginosa; Sputum

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; BACTERIAL GENE; BACTERIAL LOAD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE EXACERBATION; GENE SEQUENCE; HUMAN; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; POLYMERASE CHAIN REACTION; PREVALENCE; PREVOTELLA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; SPUTUM ANALYSIS; STREPTOCOCCUS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84901801222     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/2049-2618-1-27     Document Type: Article

References (34)

1. Dinwiddie R. Pathogenesis of lung disease in cystic fibrosis. Respiration 2000, 67:3-8. 10.1159/000029453, 10705255.
2. Marks MI. Clinical significance of Staphylococcus aureus in cystic fibrosis. Infection 1990, 18:53-56. 10.1007/BF01644186, 2107147.
3. Stone A, Quittell L, Zhou J, Alba L, Bhat M, DeCelie-Germana J, Rajan S, Bonitz L, Welter JJ, Dozor AJ, Gherson I, Lowy FD, Saiman L. Staphylococcus aureus nasal colonization among pediatric cystic fibrosis patients and their household contacts. Pediatr Infect Dis J 2009, 28:895-899. 10.1097/INF.0b013e3181a3ad0a, 20135845.
4. Govan JR, Nelson JW. Microbiology of lung infection in cystic fibrosis. Br Med Bull 1992, 48:912-930.
5. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004, 23:146-158. 10.1183/09031936.03.00057003, 14738247.
6. Goss CH, Burns JL. Exacerbations in cystic fibrosis: 1: epidemiology and pathogenesis. Thorax 2007, 62:360-367. 10.1136/thx.2006.060889, 2092469, 17387214.
7. Costerton JW. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 2001, 9:50-52. 10.1016/S0966-842X(00)01918-1, 11173226.
8. Heijerman H. Infection and inflammation in cystic fibrosis: a short review. J Cyst Fibros 2005, 4(Suppl 2):3-5.
9. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002, 15:194-222. 10.1128/CMR.15.2.194-222.2002, 118069, 11932230.
10. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, Penvari C, Kaess H, Deterding RR, Accurso FJ, Pace NR. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 2007, 104:20529-20533. 10.1073/pnas.0709804104, 2154465, 18077362.
11. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, Young VB, LiPuma JJ. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 2012, 109:5809-5814. 10.1073/pnas.1120577109, 3326496, 22451929.
12. Sibley CD, Grinwis ME, Field TR, Parkins MD, Norgaard JC, Gregson DB, Rabin HR, Surette MG. McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients. J Med Microbiol 2010, 59:534-540. 10.1099/jmm.0.016592-0, 20093379.
13. Field TR, Sibley CD, Parkins MD, Rabin HR, Surette MG. The genus Prevotella in cystic fibrosis airways. Anaerobe 2010, 16:337-344. 10.1016/j.anaerobe.2010.04.002, 20412865.
14. Zemanick ET, Wagner BD, Sagel SD, Stevens MJ, Accurso FJ, Harris JK, Harris JK. Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens. PLoS One 2010, 5:e15101. 10.1371/journal.pone.0015101, 2994853, 21152087.
15. Huang YJ, Lynch SV. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med 2011, 5:809-821. 10.1586/ers.11.76, 3359942, 22082166.
16. Daniels TW, Rogers GB, Stressmann FA, van der Gast CJ, Bruce KD, Jones GR, Connett GJ, Legg JP, Carroll MP. Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. J Cyst Fibros 2013, 12:22-28. 10.1016/j.jcf.2012.05.008, 22717533.
17. Stressmann FA, Rogers GB, van der Gast CJ, Marsh P, Vermeer LS, et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 2012, 67:867-873. 10.1136/thoraxjnl-2011-200932, 22707521.
18. Filkins LM, Hampton TH, Gifford AH, Gross MJ, Hogan DA, Sogin ML, Morrison HG, Paster BJ, O'Toole GA. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol 2012, 194:4709-4717. 10.1128/JB.00566-12, 3415522, 22753064.
19. Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, Wolfgang MC. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 2012, 7:e45001. 10.1371/journal.pone.0045001, 3458854, 23049765.
20. Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, Accurso FJ, Laguna TA. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One 2013, 8:e62917. 10.1371/journal.pone.0062917, 3639911, 23646159.
21. Stressmann FA, Rogers GB, Marsh P, Lilley AK, Daniels TW, Carroll MP, Hoffman LR, Jones G, Allen CE, Patel N, Forbes B, Tuck A, Bruce KD. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?. J Cyst Fibros 2011, 10:357-365. 10.1016/j.jcf.2011.05.002, 21664196.
22. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, Wu B, Tran D, Koff J, Kleinhenz ME, Nielson D, Brodie EL, Lynch SV. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 2010, 5:e11044. 10.1371/journal.pone.0011044, 2890402, 20585638.
23. Lim YW, Schmieder R, Haynes M, Willner D, Furlan M, Youle M, Abbott K, Edwards R, Evangelista J, Conrad D, Rohwer F. Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities. J Cyst Fibros 2013, 12:154-164.
24. Gifford AH, Moulton LA, Dorman DB, Olbina G, Westerman M, Parker HW, Stanton BA, O'Toole GA. Iron homeostasis during cystic fibrosis pulmonary exacerbation. Clin Transl Sci 2012, 5:368-373. 10.1111/j.1752-8062.2012.00417.x, 3419499, 22883617.
25. Visualization and Analysis of Microbial Population Structures. [http://vamps.mbl.edu].
26. NCBI website. [http://www.ncbi.nlm.nih.gov/sra].
27. Maeda H, Fujimoto C, Haruki Y, Maeda T, Kokeguchi S, Petelin M, Arai H, Tanimoto I, Nishimura F, Takashiba S. Quantitative real-time PCR using TaqMan and SYBR green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunol Med Microbiol 2003, 39:81-86. 10.1016/S0928-8244(03)00224-4, 14557000.
28. Horz HP, Vianna ME, Gomes BP, Conrads G. Evaluation of universal probes and primer sets for assessing total bacterial load in clinical samples: general implications and practical use in endodontic antimicrobial therapy. J Clin Microbiol 2005, 43:5332-5337. 10.1128/JCM.43.10.5332-5337.2005, 1248440, 16208011.
29. Warnes GR. gplots: Various R programming tools for plotting data. R package version 3.0.1. 2013 2013, 2013:2013. [http://cran.r-project.org/web/packages/gplots/].
30. Stacklies W, Redestig H, Scholz M, Walther D, Selbig J. pcaMethods - a bioconductor package providing PCA methods for incomplete data. Bioinformatics 2007, 23:1164-1167. 10.1093/bioinformatics/btm069, 17344241.
31. Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O'Hara RB, Simpson GL, Solymos P, Stevens MHH, Wagner H. R package Version 2.0-5 2012, Vegan: Community Ecology Package.
32. van der Gast CJ, Walker AW, Stressmann FA, Rogers GB, Scott P, Daniels TW, Carroll MP, Parkhill J, Bruce KD. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J 2011, 5:780-791. 10.1038/ismej.2010.175, 3105771, 21151003.
33. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006, 103:8487-8492. 10.1073/pnas.0602138103, 1482519, 16687478.
34. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci USA 2008, 105:15070-15075. 10.1073/pnas.0804326105, 2567494, 18812504.